Erythromycin confirmation

This has been confirmed in activity studies where the rates of metabolism of midazolam [19] and erythromycin [14] have been studied in microsomes from... 

The authors proposed that in this case erythromycin had inhibited sertraline metabolism by inhibiting CYP3A. This could have led to increased concentrations of sertraline and signs of serotonin toxicity. Unfortunately sertraline concentrations were not measured to confirm this suggestion. 

Increased clozapine serum concentrations have been reported with erythromycin (199,200) and can cause adverse effects (SEDA-21, 55). However, in 12 healthy men who took a single dose of clozapine 12.5 mg alone or in combination with a daily dose of erythromycin 1.5 g, the metabolism of clozapine was not altered (201). This confirms that CYP3A4 is a relatively minor pathway for clozapine metabolism, in contrast to CYP1A2. 

Dubois et al. [59] determined the macrolides tylosin, tilmicoson, spiramycin, josamycin, and erythromycin in swine and bovine muscle, kidney and liver tissue, in bovine milk, and in hen eggs, using roxithromycin as IS. The method involves extraction in a Tris buffer, protein precipitation, SPE clean-up on a Oasis HLB cartridge, and LC-MS-MS analysis in SRM mode. All analytes were confirmed by four ions with an ion-ratio reproducibility ranging from 2.4 to 15%. The sample throughput is 50 samples per analyst per day. Draisci et al. [60] developed a confirmatory method for tylosin, tilmicosin, and erythromycin in bovine muscle, liver, and kidney. The quantification limits were 30, 20, and 50 pg/kg in mnscle, 40, 150, and 50 pg/kg in liver, and 40, 150, 80 pg/kg in kidney for tylosin, tilmicoson, and eiythromycin, respectively. Horie et al. [61] reported the multiresidne determination of erythromycin, oleandromycin, litasamycin, josamycin, mirosamycin, spiramycin, tilmicoson, and tylosin in meat and fish. The LOQ was 10 pg/kg in positive-ion LC-ESI-MS in SIM mode. 

Yano et al. performed their crystallization in the presence of erythromycin (21), but no density corresponding to this was found. They did use the AUTODOCK program, however, to confirm that this substrate can fit in an orientation that allows the expected metabolite to form. This docking pose was in agreement with SDM experiments [40-44], It was proposed that the sugar of erythromycin formed hydrogen bonds with arg212. 

Forty eight (30%) of the E. faecium isolates, two (3%) of the E. durans isolates, and six (12%) of the E. faecalis isolates exhibited multidrug resistance. Ten percent of E. faecium, 0% of E. durans, and 17% of E. faecalis strains showed simultaneous resistance to three drugs (rifampicin, erythromycin, and ciprofloxacin or nitrofurantoin). For all E. faecium, E. durans, and E. faecalis isolates, 55 (19%) multidrug resistant strains were resistant to rifampicin, 55 (19%) strains were resistant to erythromycin, nine (2%) strains were resistant to ciprofloxacin, and one (0.3%) strain was resistant to nitrofurantoin. The incidence of multiple resistance to five or more antimicrobials of enterococcal cheese isolates was confirmed by Teuber et al. (1999) and Franz et al. (2001). In this respect it may be stated that the enterococcal isolates from Bryndza cheese have simultaneous resistance to fewer antimicrobials compared to the above-mentioned cheese isolates. 

Solid-state NMR has been used extensively for characterizing the structures of N-desmethylnefopam HC1 (38), patellin (39), erythromycin A dihydrate (40), and the amorphous nature of ursodeoxycholic acid (41). The conformations of 3 -amino-3 -deoxythymidine (42), gramicidin A (43), and amiodarone HC1 (44) have been confirmed by solid-state NMR. 

On the other hand, the inhibitory effect of erythromycin, a 14-membered-ring macrolide, on such a peptidyltransferase reaction is markedly diminished in terms of the character of a substrate. Erythromycin inhibits poly(A)-dependent polymerization of a transferred substrate such as lysine residue linked to tRNA but not other oligonucleotide-dependent polymerization of an amino acid linked either to tRNA or to oligonucleotides such as CACCA and UACCA. It has been shown that the transfer of A-acylaminoacyl residues to puromycin (puromycin reaction) is usually stimulated by erythromycin [88, 89, 95]. Igarashi et al. [96] have also confirmed these findings. That is to say, they found that erythromycin inhibits the release of a deacylated tRNA from the P site of ribosome. The release of such a deacylated tRNA from the P site and the translocation of peptidyl-tRNA from the A site to the P site of ribosome occurs concomitantly when EF-G catalyzes the GTP-dependent movement of the ribosome and the codon-anticodon-linked mRNA-peptidyl-tRNA complex. 

The contribution of domain II to erythromycin resistance (dependent on the amount of E-peptide encoded by nucleotides at positions 1248 to 1265 in 23S rRNA) has been confirmed in the domain of E. coli 23S rRNA using deletion and point mutants [188]. 

Two tests to determine whether the ternary complex, protein-synthesizing ribosome, mRNA, and peptidyl-tRNA, is destabilized or stabilized were conducted in the presence of erythromycin. The stabilization of the ternary complex was confirmed by the profile of the footprint of the ribosome occupying the ermC message covering the leader peptide coding region [183]. 

Agneu ( neu ) Moania complains to his physician of a fever and cough. His cough produces thick yellow-brown sputum. A stain of his sputum shows many Gram-positive, bullet-shaped diplococci. A sputum culture confirms that he has pneumonia, a respiratory infection caused by Streptococcus pneumoniae, which is sensitive to penicillin, erythromycin, tetracycline, and other antibiotics. Because of a history of penicillin allergy, he is started on oral erythromycin therapy. 

Neu Moania returned to his physician s office after 1 week of erythromycin therapy (see Chapter 12). The sputum sample from his previous visit had been cultured. The results confirmed that his respiratory infection was caused by Streptococcus pneumoniae and that the organism was sensitive to penicillin, macrolides (e.g., erythromycin, clarithromycin), tetracycline, and other antibiotics. 

The location of binding of EF-Tu on ribosomes has been established directly by cryo-EM. It binds both to the L7/L12 stalk and to the body of the 505 ribosomal subunit. The other end of the P site is at the pepti-dyltransferase locus and has been photochemically labeled by azide derivatives of aminoacyl groups bound to a tRNA. The labeling is primarily in the 505 subunit of E. coli ribosomes and involves the central loop of domain V (residues 2043 - 2625) of the 235 RNA. Residues U2584 and U2585 are major sites of crosslinking (see Fig. 29-14). The presence of nearby sites of mutation leading to resistance to chloramphenicol or erythromycin (Box 29-B) served to confirm the central loop as part of the peptidyltrans-ferase. Domain II of 235 RNA is also involved, and there is evidence that the unique sequence UGG at positions 807-809 may also interact with the CCA end of tRNA in the P site. ... 

A 10-year-old girl received erythromycin for a prolonged respiratory tract infection. She continued to have headaches and a stuff - nose a facial x-ray suggested maxillary sinusitis, which could not be confirmed following sinus puncture. Erythromycin was stopped and she was given amoxicillin (250 mg three times a day) for 10 days. 

---